Premium
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
VANCOUVER, June 22 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, May 19 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, Sept. 25 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company...
VANCOUVER, June 26 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, May 24 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, March 31 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, March 17 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, March 5 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company today...
VANCOUVER, Nov. 14 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. (TSX: DDD; OTCBB: DRUG; BBSE: DRP) today announced that it has entered an agreement with an unaffiliated party for the...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 2.11 | 4.63940193492 | 45.48 | 48.35 | 40.65 | 1632 | 44.47107217 | CS |
| 4 | -10.55 | -18.1458548332 | 58.14 | 59.08 | 40.65 | 1875 | 52.76154468 | CS |
| 12 | -20.54 | -30.1482460003 | 68.13 | 69.77 | 40.65 | 3244 | 56.23943004 | CS |
| 26 | 46.14 | 3182.06896552 | 1.45 | 108 | 1.3 | 8436 | 50.87568926 | CS |
| 52 | 45.15 | 1850.40983607 | 2.44 | 108 | 1.29 | 4629 | 46.68299321 | CS |
| 156 | 32.24 | 210.03257329 | 15.35 | 108 | 1.29 | 10798 | 15.36394917 | CS |
| 260 | 17.59 | 58.6333333333 | 30 | 108 | 1.29 | 11012 | 20.20752757 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
